The Golden Age of Drug Discovery
By Stephanie Vine
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
False
By Stephanie Vine
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
October 1, 2025
When Europe considered banning titanium dioxide in medicines, the pharma world braced for upheaval. With its short-term future in medicines secured, what’s next?
4 min read
October 1, 2025
This webinar delves into the cutting-edge intersection of chemistry and biology, showcasing how targeted molecular innovation is driving the next generation of life science and diagnostics products.
10:00 am - 11:00 am GMT-4 min read
September 30, 2025
Titanium dioxide, AI, counterfeits, environmental responsibility, crazy chemistry and more. Our latest eBook explores key trends shaping small molecule drug development
By Brian Carothers
September 24, 2025
As oligonucleotides gain traction, manufacturing capabilities and analytical systems are being retooled to meet new demands for scale, purity, and efficiency.
5 min read
By Christine Allen
September 23, 2025
In the age of automation and AI, here’s how pharma formulation will benefit.
6 min read
September 18, 2025
Drug development and manufacturing technologies launched during 2025 are eligible for our annual Innovation Awards showcase.
2 min read
September 10, 2025
By exploiting GRK2 bias, researchers are redefining how β2AR modulation can be applied in type 2 diabetes and obesity management.
2 min read
By Stephanie Vine
September 5, 2025
Rocket launcher antibiotics, subscription models, and articulating value; we discuss new progress in antimicrobial therapies with Michael Murray
9 min read
By Stephanie Vine
September 2, 2025
Researchers develop new tool for evaluating API stability under various conditions.
2 min read
False
False
False